
· Executive Brief
National Prescription Drug Take Back Day, April 25, 2026
An executive-guidance framework for access, qualified response, handoffs, escalation, and learning.

Leadership signal
National Prescription Drug Take Back Day can serve as an executive operating checkpoint.
Awareness activity should not create an unsupported promise of service. Leaders can align public communication with actual entry points, qualified response capacity, emergency procedures, transition ownership, and a clear method for escalating unresolved needs.
Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.
Executive opening
Leftover medication is a discharge and dispensing problem, not only a collection event
National Prescription Drug Take Back Day, held April 25, 2026, invites communities to return unused medicines for safe disposal. For health systems, the more durable question is why so many medicines are left over, stored unsafely and never returned. The answer sits inside everyday operations: prescribing amounts, discharge teaching, pharmacy counseling, home disposal options and follow-up contact. A collection day is valuable, but it reaches only the medicines and people that arrive on that date. The rest of the year depends on whether the health system has built disposal into the care it already delivers.
Research shows how rarely disposal happens without deliberate design. In a randomized trial of 450 adult general surgery patients, 143 had leftover opioid tablets, and only 13 of them, or 9.1%, reported disposing of the unused medication.[1] A signed safe opioid agreement did not improve disposal or safe storage compared with standard education and counseling.[1]
By contrast, programs that hand families a disposal method at discharge have reported much higher disposal. After a pediatric ambulatory surgery initiative paired parent education with a home opioid disposal kit, optimal disposal rose from 11% to 58% of families.[8] The difference between those findings is an operating difference, not a difference in patient goodwill. It points executives toward the design of discharge, dispensing and follow-up rather than toward louder reminders alone.
The sections below summarize peer-reviewed evidence on burden, disposal behavior, access, equity, workforce and communication. They sit beside the executive guidance already on this page. Many studies are single-site or come from outside the United States, so leaders should treat them as signals to test locally rather than as benchmarks. The aim is a disposal pathway that works on every ordinary day, with the observance serving as the annual checkpoint for whether it does.
Current evidence
What the research says about leftovers, storage and harm
Unused medicines in the home create risk for children as well as adults. A national analysis of U.S. pediatric inpatient stays from 2016 to 2022 identified 17,555 weighted hospitalizations for opioid or cannabis poisoning, including 10,780 for opioids.[6] Opioid poisoning was associated with greater respiratory morbidity, longer hospitalization and higher charges than cannabis poisoning.[6] The authors supported safe-storage counseling and caregiver education as part of the response.[6] For health systems, those admissions are the downstream cost of medicines that stayed in reach.
Leftover opioids after surgery are common, and disposal is uncommon. In pediatric outpatient urologic surgery, 96% of families whose child was prescribed opioids had leftover medication, and 17% of parents had disposed of it at baseline.[15] After pediatric tonsillectomy, 61% of caregivers lacked plans for opioid disposal once the postoperative period was complete.[4] Among ambulatory surgery patients given a deactivation packet, the majority still had unused opioids one to two weeks after surgery.[13] Together, these studies suggest that leftover supply is the norm after many procedures, not the exception.
Storage practices add a second layer of exposure. In a multicenter survey of 221 cancer inpatients in central China, only 3.2% stored opioids under lock and key, and 49.8% were unaware of proper disposal methods.[14] Patients who had not received information on safe disposal had higher odds of unsafe disposal, with an odds ratio of 4.57.[14] That association links disposal behavior directly to whether anyone explained it. It makes counseling a measurable process step rather than a courtesy.
Medication disposal also matters beyond opioids. Six North Carolina community pharmacies with longitudinal disposal programs collected 144,084 unused, unwanted or expired prescription tablets and capsules between November 2021 and May 2023.[12] Antimicrobials made up 2.6% of those units and nearly 1.3 kg of active ingredient.[12] The authors framed disposal as an underappreciated part of antimicrobial stewardship.[12]
Population data show the same pattern at scale. In a nationally representative Indonesian survey of 616,110 people, 86.7% reported discarding medicines in household trash, and fewer than about 2% returned them to collection systems.[2] Most respondents, 75.0%, recognized expiration as a sign of damaged medicine, but awareness of other signs was substantially lower.[2] The authors called for nationwide education and accessible, structured take-back programs.[2] Although the setting differs from U.S. health systems, the gap between awareness and safe practice recurs across the studies summarized here.
Figure 1
Disposal of leftover opioids varies widely with program design
Percent of patients or families reporting disposal of leftover opioids, as defined in each study. Values are copied from the cited studies [1], [8], [13], [15]; none is estimated.
Data note. These values come from different studies, populations and definitions of disposal, so this is an indirect comparison; they show that disposal varies widely with program design, not the exact effect of any one approach.
Limitation. All values rely on self-report by patients or parents, and most come from single academic centers with small samples.
Figure data (5 rows)
| Measure | Value | Population, setting and year as reported | Source |
|---|---|---|---|
| Adult surgery patients with leftovers who disposed of them | 9.1% | 13 of 143 patients with leftover tablets in a randomized trial of 450 general surgery patients, 2022 to 2024 | [1] |
| Parents reporting optimal disposal before education and kit | 11% | 18 of 161 families after pediatric ambulatory surgery, before the quality improvement initiative | [8] |
| Ambulatory surgery patients who used a deactivation packet | 30% | Among 67 respondents with unused medication, one hospital, 2019 to 2020 | [13] |
| Parents reporting optimal disposal after education and kit | 58% | 111 of 190 families after pediatric ambulatory surgery, after the initiative | [8] |
| Families disposing after text messages and provider education | 63% | Families of children prescribed opioids after outpatient pediatric urologic surgery, 2021 cohort | [15] |

Continuum of care
Disposal starts at the prescription and ends at the follow-up call
The disposal pathway begins long before a take-back event. It starts with the amount prescribed, continues through discharge teaching and pharmacy dispensing, and ends only when the leftover medicine leaves the home. Each step has a different owner, and the patient often carries the final step alone. When no one owns the last step, the medicine simply stays in the cabinet. Executives can map who is accountable at each point and where the handoff to the patient happens without support.
Prescribing and education can move together. A pediatric urology quality improvement program combined surgeon education on opioid use with automated text messages to families after surgery.[15] The share of patients prescribed opioids fell to 26%, and 63% of families who received opioids reported disposal.[15] Families used a median of 3 doses at baseline and 2 doses after the change.[15] Fewer leftovers and higher disposal reinforced each other, which is why prescribing and disposal belong in the same improvement plan.
Handing patients a disposal method at discharge is a recurring theme. In a difference-in-differences study of 1,321 orthopedic surgery patients, disposal kits were associated with a 10.5 percentage point increase in the fraction of opioids disposed.[9] The same study reported a 10.6 percentage point increase in disposal rates, with a confidence interval that crossed zero.[9] In the pediatric ambulatory surgery initiative, safe disposal rose from 34% to 66% after education and a home kit.[8]
Kits do not close the loop by themselves. Among 67 ambulatory surgery patients with unused opioids, 30% used the deactivation packet they received at discharge.[13] Common reasons for nonuse were procrastination, holding medicine in case of future pain and waiting to dispose of several medicines at once.[13] The authors suggested partial prescription fills and reminder systems as next steps.[13] A disposal method is necessary, but follow-up contact may decide whether it is used.
Hospice shows the end-of-life version of the same continuum. A one-hour online training for hospice clinical staff was followed by more staff reporting that they always educated patients about disposal at admission, rising from 31% to 46%.[3] Routine disposal with patients and families rose from 73% to 83%.[3] In home hospice, the clinician is present when medicines become unneeded, which makes disposal part of the visit rather than a task left to grieving families.
Figure 3
Why the pathway breaks
People
- Pharmacists lack time due to workload
- Staff lack training on disposal counseling
- Patients keep medicine in case of future pain
Process
- Disposal not addressed at discharge or dispensing
- No follow-up reminder after surgery
- Agreements added without a disposal method
Technology
- No automated post-discharge messages
- No site locator for nearby collection points
- Disposal kits not stocked at discharge
Environment
- Few permanent collection sites in rural areas
- Medicines stored where children can reach them
- Waste infrastructure gaps
Policy
- Default prescription quantities exceed typical use
- No partial fill option offered
- Unclear ownership of disposal across settings
Measurement
- Disposal rarely measured after discharge
- Results not stratified by group or site
- Take-back volume counted without denominators
Unranked qualitative cause-and-effect diagram for the outcome in the box: Leftover prescription medicines remain in homes and are stored or discarded unsafely Causes are assembled from the cited literature [1], [2], [3], [4], [6], [10], [13], [14], [15]; categories are not weighted and their order carries no meaning.
Data note. Qualitative; no frequencies are implied.
Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.
Figure data (6 rows)
| Category | Causes drawn from the cited literature |
|---|---|
| People | Pharmacists lack time due to workload; Staff lack training on disposal counseling; Patients keep medicine in case of future pain |
| Process | Disposal not addressed at discharge or dispensing; No follow-up reminder after surgery; Agreements added without a disposal method |
| Technology | No automated post-discharge messages; No site locator for nearby collection points; Disposal kits not stocked at discharge |
| Environment | Few permanent collection sites in rural areas; Medicines stored where children can reach them; Waste infrastructure gaps |
| Policy | Default prescription quantities exceed typical use; No partial fill option offered; Unclear ownership of disposal across settings |
| Measurement | Disposal rarely measured after discharge; Results not stratified by group or site; Take-back volume counted without denominators |
Access
Access means a disposal option at the moment of need
A once-a-year collection day reaches people who can attend at that time and place. Everyone else depends on permanent options such as pharmacy kiosks, mail-back envelopes or in-home deactivation products. Access therefore depends on whether a usable option is available when the medicine becomes unneeded. For surgical patients, that is often one to two weeks after discharge. For hospice families, it is after a death. For parents, it may be after a child recovers early.
Awareness of existing options is low. In a survey of 538 residents of the United Arab Emirates, only 29.2% were aware of pharmacy take-back programs.[5] Key barriers included limited awareness and limited accessibility of disposal programs.[5] Among 108 undergraduate students in another survey, 56.5% had never used a community pharmacy for safe medication disposal, and household waste was the most common method at 67.6%.[7]
Community-level programs can expand access, but measurable effects are harder to show. The Communities That HEAL trial randomized 67 communities in Kentucky, Massachusetts, New York and Ohio.[11] It found no statistically significant difference between intervention and wait-list communities in high-risk opioid prescribing or in other outcomes, including the number of locations providing drug take-back services.[11] Both arms improved, which the authors linked to possible outside events such as revised national prescribing guidelines.[11]
Convenience at discharge appears to matter most. Placing a home disposal kit in families’ hands before discharge, paired with education, was associated with higher optimal disposal.[8] Health systems that own outpatient pharmacies can test whether every opioid dispensing includes a disposal option, a counseling note and a nearby collection site. Pharmacy disposal programs can also produce measurable volumes, as the North Carolina pharmacies showed, which helps leaders track whether access is being used.[12]
Executives can also review physical access. Are collection kiosks placed in pharmacies, clinics and emergency departments where patients actually go? Are hours, parking and signage usable for older adults and people with disabilities? These questions turn access from an assumption into something the organization can inspect. A simple audit, in which staff try to use each kiosk and mail-back option as a patient would, often reveals barriers that a site list does not show.
Executive guidance · System route
Build one visible operating route for National Prescription Drug Take Back Day.
Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.
The route at a glance
- Make access clear
- Protect privacy
- Protect respectful continuity
- Hold the transition
- Learn without stigma
Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.
Make access clear
Use respectful, plain-language instructions that identify approved contact options and what a person can expect next.
Protect privacy
Review channels, spaces, documentation, and role access against organizational policy and applicable requirements.
Protect respectful continuity
Align clear access, privacy, qualified response, approved escalation, and transition ownership without making assumptions about any person.
Hold the transition
Confirm acceptance when responsibility moves, and use approved escalation when the next owner is unavailable.
Learn without stigma
Review delays, drop-offs, repeat contacts, and experience feedback to improve the system rather than judge the person.
Figure 2
The system route as one flow
The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.
Data note. Shows sequence and handoffs only; it carries no counts or rates.
Limitation. Local processes may add, merge or reorder stages under organizational policy.
Figure data (5 rows)
| Stage | What the stage requires |
|---|---|
| Make access clear | Use respectful, plain-language instructions that identify approved contact options and what a person can expect next. |
| Protect privacy | Review channels, spaces, documentation, and role access against organizational policy and applicable requirements. |
| Protect respectful continuity | Align clear access, privacy, qualified response, approved escalation, and transition ownership without making assumptions about any person. |
| Hold the transition | Confirm acceptance when responsibility moves, and use approved escalation when the next owner is unavailable. |
| Learn without stigma | Review delays, drop-offs, repeat contacts, and experience feedback to improve the system rather than judge the person. |
Equity and trust
Disposal gaps follow geography, education and information
Disposal behavior differs by place. In the Indonesian national survey, rural residents were more likely to burn, bury or store medicines, while urban residents showed slightly higher awareness of warning signs beyond expiration.[2] Areas such as Maluku-Papua relied more on informal disposal methods.[2] The authors linked these differences to waste management infrastructure, healthcare access and pharmaceutical service availability.[2]
Information reaches people unevenly. Among cancer patients in central China, 19.5% reported receiving information on safe storage or disposal of opioids, and only 10.0% received disposal information specifically.[14] Patients with an associate degree, a bachelor’s degree or higher were less likely to dispose of opioids unsafely.[14] Education should therefore be designed for every literacy level, not assumed from a printed handout. Plain language, teach-back and translated instructions are practical ways to reach patients who are least likely to receive disposal information today.
Uptake of disposal tools can also differ by group. In the ambulatory surgery packet study, women were more likely than men to use the packet, at a predicted probability of 30.2% versus 10.4%.[13] Patients aged 18 to 25 used it more often than those aged 26 to 40.[13] The UAE survey found that a medical background, prior advice and routinely checking for expired medicines predicted awareness.[5] Each pattern suggests that disposal tools and messages are not reaching all groups equally, and that uptake should be measured by group rather than assumed.
Safety-net settings deserve deliberate attention. The randomized surgical trial included a county safety-net hospital alongside private surgical clinics, and disposal remained rare across the study.[1] Leaders can review disposal outcomes by payer, language, neighborhood and site of care to see whether some patients receive less teaching or fewer tools. Results stratified this way give boards a clearer picture than a single systemwide rate, and they show where a targeted fix would reach the most people.
Trust is built when instructions are consistent across settings. A family that hears one disposal message at discharge, another at the pharmacy and a third from a community event may do nothing. Aligning those messages is an equity measure as well as a communication task. Community partners, including faith groups, senior centers and local pharmacies, can help carry one consistent message to neighborhoods where health system channels reach fewer people.

Human infrastructure
Pharmacists, nurses and hospice teams carry the message
Disposal guidance depends on the people who dispense and discharge. Pharmacists, discharge nurses, surgeons, hospice clinicians and community health workers each have a moment to explain what to do with leftover medicine. Whether they use it depends on time, training and a clear expectation.
Pharmacists report specific barriers. In a survey of 370 pharmacists in the United Arab Emirates, the most cited barrier was lack of public awareness, at 88.9%.[10] Lack of time due to workload followed at 82.4%, and lack of training at 78.1%.[10] Most pharmacists, 97.6%, supported collaboration with public health agencies on disposal awareness.[10] The leading perceived cause of unused medication was prescription changes after poor clinical outcomes, cited by 83.8%.[10]
Training can change staff practice. After one hour of online training, more hospice clinical staff reported educating patients on disposal at every admission.[3] The study followed a 2018 federal law allowing hospice staff to dispose of patient medications in the home, which created a new duty that required preparation.[3] Medical record review in the same study examined how often each disposal method was used, giving the organization a way to check practice rather than rely on self-report.[3]
Future pharmacists also need preparation. The undergraduate survey found inconsistent disposal practice and variable confidence, influenced by knowledge and educational exposure.[7] The authors proposed a structured pharmacy curriculum that progresses from awareness to applied practice, patient education and community engagement.[7] Health systems that host pharmacy and nursing students can model that progression through rotations that include disposal counseling. Rotations are a practical place to build that habit before graduates enter the workforce.
For health systems, the workforce question is concrete. Is disposal counseling built into discharge and dispensing workflows, or does it depend on individual initiative? Is there time to deliver it? Do staff know which local collection sites and products are available? Clear answers turn a recognized duty into a routine step. Leaders can also ask whether disposal counseling is included in competency checks, orientation for new discharge nurses and pharmacy technician training. Where workload is the barrier, brief scripted counseling and automated follow-up messages can share the load rather than adding another task to a crowded discharge.
Executive guidance · Operating dashboard
Use a small dashboard to expose friction and ownership.
Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.
Four operating signals
Each signal pairs an executive question with one candidate local measure, set out below.
Executive guidance · Signal
Access clarity
Can people understand where to begin and what will happen after contact?
- Candidate local measure
- Locally defined contact, routing, response, and repeat-contact signals.
Executive guidance · Signal
Privacy reliability
Do channels, roles, and spaces support organizational privacy expectations?
- Candidate local measure
- Reported privacy barriers, process exceptions, training needs, and corrective-action status.
Executive guidance · Signal
Respectful continuity
Can people reach qualified support and remain connected through transitions without stigma or unowned work?
- Candidate local measure
- Locally defined access barriers, repeat contacts, unaccepted transfers, escalation, and experience feedback.
Executive guidance · Signal
Experience and learning
Can people and staff identify barriers without stigma or futility?
- Candidate local measure
- Feedback themes, assigned improvements, response status, and verified changes.
Figure 4
The operating system behind the dashboard
The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.
Data note. Structural diagram; no measured values.
Limitation. Owners are candidates to be confirmed locally.
Figure data (4 rows)
| Operating signal | Candidate owner |
|---|---|
| Access clarity | Executive sponsor and operational lead |
| Privacy reliability | Operational owner and participating teams |
| Respectful continuity | Sending and receiving owners |
| Experience and learning | Improvement owner and executive sponsor |
Executive guidance · Handoff workflow
Close the loop across teams, settings, and partners.
A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.
How responsibility moves
Lane A
From message to accepted ownership
- Confirm the approved message and intended audience.
- Publish the actual entry point and receiving role.
- Acknowledge receipt using the locally approved method.
- Escalate when ownership or response remains unclear.
Lane B
From accepted ownership to verified follow-through
- Record the next accountable owner and visible status.
- Use the approved private channel, name the qualified receiver, and preserve visibility under local escalation policy.
- Keep unresolved work visible across boundaries.
- Confirm closure or document the continuing exception.
Executive guidance · Executive scorecard
Give leaders one view of route reliability and improvement.
The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.
Who reviews what
- Executive sponsor and operational lead
- Operational owner and participating teams
- Sending and receiving owners
- Improvement owner and executive sponsor
Candidate owners named in the scorecard, confirmed locally.
| Operating signal | Executive question | Candidate owner | Suggested review point |
|---|---|---|---|
| Access clarity | Can people understand where to begin and what will happen after contact? | Executive sponsor and operational lead | At campaign launch and close |
| Privacy reliability | Do channels, roles, and spaces support organizational privacy expectations? | Operational owner and participating teams | At a locally defined cadence |
| Respectful continuity | Can people reach qualified support and remain connected through transitions without stigma or unowned work? | Sending and receiving owners | At a locally defined cadence |
| Experience and learning | Can people and staff identify barriers without stigma or futility? | Improvement owner and executive sponsor | Until action is verified |
Figure 5
Control points for a reliable medication disposal pathway
| Control point | Risk if missing | Owner | Evidence of control |
|---|---|---|---|
| Opioid prescribing quantities reviewed against typical use | Large leftover supplies in homes | Chief medical officer and surgical department chairs | Periodic report of prescribed versus used doses by procedure |
| Disposal method provided at discharge or dispensing | Families intend to dispose but have no convenient way | Pharmacy director and nursing leadership | Share of opioid discharges with a kit or site information documented |
| Post-discharge reminder with disposal instructions | Leftover medicine forgotten after recovery | Patient experience and digital health leads | Message delivery and response logs |
| Staff training on disposal and safe storage counseling | Inconsistent or absent counseling | Clinical education director | Training completion and observed counseling audits |
| Collection kiosk placement and access review | Sites unused or unreachable for some patients | Ambulatory operations leader | Annual map of kiosk locations, hours and accessibility |
| Stratified disposal and storage measures | Gaps by payer, language or neighborhood stay hidden | Quality and analytics lead | Quarterly stratified dashboard reviewed by a board committee |
Control points derived from the cited evidence [1], [3], [5], [8], [9], [10], [13], [15] and this brief’s executive guidance.
Data note. Each row is a control to verify, not a measured result.
Limitation. Owners and evidence of control must follow local policy and applicable requirements.
Public communication
Clear, timely messages make disposal the easy choice
Public messaging around Take Back Day can raise awareness, but evidence suggests timing and specificity matter more than volume. Messages work best when they reach a person at the moment medicine becomes leftover and when they name a concrete next step. A general call to clean out the medicine cabinet is useful once a year. A message on day seven after surgery, with the nearest kiosk address, may be more useful still.
Just-in-time messages show promise. In the pediatric urology program, automated text messages after surgery included disposal instructions and a link to search for nearby disposal sites.[15] Most parents, 96%, reported satisfaction with the messages, and the authors noted the program required little additional staff effort.[15] That matters for organizations where discharge time is already scarce, because an automated message can reach families at home without another call.
Channel preferences vary. In the UAE survey, social media was the most preferred educational platform at 61.9%, followed by pharmacists at 54.6% and physicians at 28.4%.[5] Although 76.2% recognized environmental risks of improper disposal, 61.5% still discarded solid medicines in household garbage.[5] Knowledge alone did not translate into practice.[5] Health systems can combine channels, using social media for awareness and pharmacists or nurses for the specific instruction at the point of care.
Clinical messages also need consistency. Families of children after tonsillectomy were broadly unaware of safe disposal methods, and the authors called for more comprehensive counseling.[4] In the randomized surgical trial, adding a signed agreement to standard counseling did not raise disposal, which suggests that more paperwork is not the same as clearer communication.[1]
During this observance, leaders can test a simple question. If a patient calls about leftover medicine, does the first person they reach know the nearest collection option and the in-home choice? Can they say who answers follow-up questions? The answer shows whether public messaging matches the service behind it. Leaders can also review the materials themselves. Are discharge instructions, pharmacy leaflets, patient portal messages and community event flyers consistent about where and how to dispose of medicine? Do they mention safe storage until disposal, especially in homes with children? A single reviewed message set, used across every channel, is a modest change that removes conflicting advice.

Executive guidance · 90-day plan
Turn the observance into one sustained operating change.
The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.
Ninety days, three moves
- Days 1–30See the current route
- Days 31–60Build the reliable path
- Days 61–90Make the change visible
Days 1–30 · Listen and map
See the current route
- Name an executive sponsor and an operational owner.
- Listen to people using the route and representative frontline teams.
- Map how National Prescription Drug Take Back Day communications connect to real entry points, owners, transitions, and escalation.
- Select one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and test
Build the reliable path
- Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
- Validate the design with every sending and receiving team involved.
- Test one respectful access-to-qualified-support handoff and remove a verified privacy, clarity, or ownership barrier.
- Test the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verify
Make the change visible
- Launch the redesigned route with a small set of locally defined measures.
- Review unresolved work and recurring friction using a learning approach.
- Correct implementation barriers and record who owns each remaining dependency.
- Report what changed, what evidence was reviewed, and what still requires live oversight.
Figure 6
The 90-day plan on one timeline
The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.
Data note. Time boxes are a management framework, not a clinical timeline.
Limitation. Durations are uniform 30-day windows; real tasks may span windows.
Figure data (12 rows)
| Window | Action |
|---|---|
| Days 1–30 · Listen and map | Name an executive sponsor and an operational owner. |
| Days 1–30 · Listen and map | Listen to people using the route and representative frontline teams. |
| Days 1–30 · Listen and map | Map how National Prescription Drug Take Back Day communications connect to real entry points, owners, transitions, and escalation. |
| Days 1–30 · Listen and map | Select one recurring barrier that the organization can responsibly address. |
| Days 31–60 · Design and test | Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal. |
| Days 31–60 · Design and test | Validate the design with every sending and receiving team involved. |
| Days 31–60 · Design and test | Test one respectful access-to-qualified-support handoff and remove a verified privacy, clarity, or ownership barrier. |
| Days 31–60 · Design and test | Test the route in more than one representative setting or operating period where practical. |
| Days 61–90 · Implement and verify | Launch the redesigned route with a small set of locally defined measures. |
| Days 61–90 · Implement and verify | Review unresolved work and recurring friction using a learning approach. |
| Days 61–90 · Implement and verify | Correct implementation barriers and record who owns each remaining dependency. |
| Days 61–90 · Implement and verify | Report what changed, what evidence was reviewed, and what still requires live oversight. |
Executive guidance · Leadership close
Make National Prescription Drug Take Back Day a starting point, not an endpoint.
Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.
Leadership commitment
Make ownership visible, test the route, and report what improved.
Executive action kit · Day observance
Turn National Prescription Drug Take Back Day into accountable action.
An executive-guidance framework for access, qualified response, handoffs, escalation, and learning.
Leadership focus
Use this observance to examine psychological safety, timely connection, privacy, and continuity. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.
Workforce lens
Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the support, referral, privacy, escalation, and continuity pathway.
Patient and community lens
Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.
Equity and access lens
Review stigma, language, cultural safety, disability access, geography, cost, and digital barriers without assuming the same experience for every person.
Five-minute briefing
Inspect the operating sequence
Listen with people seeking support, behavioral health teams, emergency pathways, primary care, and community partners. Find one stigma, unclear ownership, a failed connection, or a privacy concern, then test the locally approved route from entry through acknowledged follow-through.
- Make access clear
- Protect privacy
- Protect respectful continuity
- Hold the transition
- Learn without stigma
Leadership actions for this week
- Name an executive sponsor and frontline operating owner.
- Ask people using and operating the pathway where ownership becomes unclear.
- Test one representative route from first question to acknowledged next step.
- Select one barrier that can be corrected without overstating the evidence.
- Set a review date and define how completion will be verified.
Candidate measures
Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.
- Locally defined contact, routing, response, and repeat-contact signals.
- Reported privacy barriers, process exceptions, training needs, and corrective-action status.
- Locally defined access barriers, repeat contacts, unaccepted transfers, escalation, and experience feedback.
Department readiness checklist
- The public and staff entry points match the actual approved process.
- A specific role accepts each request, referral, or escalation.
- Handoffs include acknowledgment and a visible unresolved state.
- Language, disability, digital, transportation, and trust barriers receive explicit review.
- Communications do not introduce unsupported themes, statistics, or clinical advice.
- A named leader will review what changed after the observance.
Intended audiences
- Executive and Operational Leaders
- Public Health and Community Partners
- Patient Experience and Access Leaders
Staff communication template
During National Prescription Drug Take Back Day, our organization will connect awareness with a practical review of the support, referral, privacy, escalation, and continuity pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.
Community communication template
National Prescription Drug Take Back Day is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.
Measurement worksheet
- Signal
- What observable condition will show whether the route works?
- Definition
- What is included, excluded, and counted?
- Owner
- Who reviews the signal and acts on exceptions?
- Cadence
- When will leaders review it?
- Equity check
- Which differences require protected, locally appropriate review?
- Closure
- What evidence will confirm the improvement was completed?
- Editorial review
- Completed
- Source records
- 2 listed under Authoritative resources
- Review standard
- Sourced facts remain separated from original executive guidance
- Clinical boundary
- No new statistical or clinical claim was added by this action kit
Sources and content boundary
Authoritative resources
Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.
Peer-reviewed references
References
Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .
- 1.Stulberg JJ, Truong VTT, Schäfer WL, Iroz CB, Chamely EA, Johnson JK. Preventing Opioid Misuse Through Safe Opioid Use Agreements in Surgery: A Randomized Clinical Trial. Journal of the American College of Surgeons. 2026. https://doi.org/10.1097/xcs.0000000000002121
- 2.Alfian SD, Griselda M, Khoiry QA, Pratama MA, Febriyanti RM, Saw PS, et al. Unsafe disposal of unused and expired medicines in Indonesia: nationwide evidence on public awareness and disposal practices across urban–rural and island disparities. BMC Public Health. 2026;26(1):2102. https://doi.org/10.1186/s12889-026-27672-y
- 3.Godzik CM, Waliji-Banglawala A, Tjia J, Brennan CW, Wood O, Murphy M, et al. Knowledge, Attitudes, and Practices Surrounding Safe Medication Disposal in a Hospice Setting. Journal of Pain and Symptom Management. 2026;71(1):1-7. https://doi.org/10.1016/j.jpainsymman.2025.05.008
- 4.Maddineni S, Vendra V, Khan H, Ali N, Valdez T, Messner A, et al. Cohort study of opioid utilization in post-tonsillectomy pediatric patients. American Journal of Otolaryngology. 2026;47(4):104858. https://doi.org/10.1016/j.amjoto.2026.104858
- 5.Muwanga VM, Alex R, Majdoub MZ, Khatoon M, Abuzaid J, Gulam SM. Knowledge, attitudes, and practices of drug disposal in the United Arab Emirates. Journal of Public Health Research. 2026;15(1):22799036251411568. https://doi.org/10.1177/22799036251411568
- 6.Fournier L, Shehadeh S, Saied MH, Maman D, Pillar G. Pediatric opioid and cannabis poisoning hospitalizations in the United States, 2016–2022: a national age-matched inpatient analysis. Frontiers in Pediatrics. 2026;14:1904477. https://doi.org/10.3389/fped.2026.1904477
- 7.Low BY, Rainford K. Medication disposal knowledge, attitude and practice among undergraduates: Implications for pharmacy education. Currents in Pharmacy Teaching and Learning. 2026;18(10):102692. https://doi.org/10.1016/j.cptl.2026.102692
- 8.Stone AL, Favret LH, Luckett T, Nelson SD, Quinn EE, Potts AL, et al. Association of Opioid Disposal Practices with Parental Education and a Home Opioid Disposal Kit Following Pediatric Ambulatory Surgery. Anesthesia & Analgesia. 2025;140(6):1461-1469. https://doi.org/10.1213/ane.0000000000007104
- 9.Shan E, Xiong R, Katzman M, Ali Z, Lee D, Delgado MK, et al. Effect of providing at-home opioid disposal kits at discharge after an orthopaedic surgery. BMJ Open Quality. 2025;14(1):e003040. https://doi.org/10.1136/bmjoq-2024-003040
- 10.Abbas MO, Beshir S, Kamal AlKhalidi D, Shamseldin Al Gailani Ali E, Lozon Y, Assadi RA, et al. UAE pharmacists’ perceptions of the causes of unwanted or unused medications, their practices, and barriers to promoting safe medication disposal by the public. BMC Public Health. 2025;25(1):236. https://doi.org/10.1186/s12889-025-21332-3
- 11.Levin FR, Oyler DR, Babineau DC, Villani J, Chandler RK, Freeman PR, et al. Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing?. AJPM Focus. 2025;4(6):100371. https://doi.org/10.1016/j.focus.2025.100371
- 12.Hoskins E, Bickenbach EM, Buchanan M, Detter S, Ferguson M, Freeman A, et al. Quantifying Antimicrobial Disposals at Six Community Pharmacies With Longitudinal Medication Disposal Programs: An Underappreciated Component of a One Health Approach to Antimicrobial Stewardship. Open Forum Infectious Diseases. 2025;12(10):ofaf040. https://doi.org/10.1093/ofid/ofaf040
- 13.Oles WC, Vilsmark ES, Magoon C, Weathersbee K, Melaragni F, Barreveld AM. Evaluation of a drug deactivation system for safe disposal of opioids after ambulatory surgery. Journal of the American Pharmacists Association. 2024;64(6):102247. https://doi.org/10.1016/j.japh.2024.102247
- 14.Zhang M, Chen H, Luo C, Wang X, Liu L, Wu D, et al. Storage, Disposal, and Use of Opioids Among Cancer Patients in Central China: A Multi-Center Cross-Sectional Study. The Oncologist. 2024;29(7):e941-e948. https://doi.org/10.1093/oncolo/oyae049
- 15.Mohankumar K, Rossman AH, Yong R, Thao A, Sheridan K, Roth EB. Opioid prescription usage and disposal after provider education and SMS-based parent education. Journal of Pediatric Urology. 2024;20(3):497.e1-497.e6. https://doi.org/10.1016/j.jpurol.2024.03.001
Claim-to-source matrix
What each source supports
Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.
| Claim group | Sources | Years | Used in | Limitation |
|---|---|---|---|---|
| Pediatric poisoning burden from opioids in the home | [6] | 2026 | Current evidence | Administrative inpatient data from 2016 to 2022; cannot identify the source of the medicine. |
| Leftover opioids and low disposal after surgery | [1] [4] [13] [15] | 2026, 2024 | Current evidence | Self-reported disposal; single academic systems; small pediatric cohorts. |
| Home disposal kits and education at discharge | [8] [9] [13] | 2025, 2024 | Continuum of care | Pre-post and difference-in-differences designs; one kit effect estimate had a confidence interval crossing zero. |
| Staff training and pharmacist barriers | [3] [7] [10] | 2026, 2025 | Human infrastructure | Self-reported surveys; single hospice; UAE pharmacists and undergraduates may not reflect U.S. practice. |
| Population awareness, access and geographic disparities | [2] [5] [14] | 2026, 2024 | Equity and trust | Non-U.S. cross-sectional surveys; self-reported practices; online and convenience samples. |
| Community and pharmacy disposal programs | [11] [12] | 2025 | Access | Community trial with no significant differences and possible outside influences; geographically limited pharmacy data. |
| Just-in-time communication to families | [5] [15] | 2026, 2024 | Public communication | Single-center quality improvement with separate cohorts; survey channel preferences do not measure behavior. |

About the author
Greg Wahlstrom
MBAHCM
President and Chief Executive Officer, The Healthcare Executive
View Greg’s profile©2014 – 2026 The Healthcare Executive. All rights reserved.

